These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1120 related items for PubMed ID: 33220608

  • 21. MiR-324/SOCS3 Axis Protects Against Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury and Regulates Myocardial Ischemia via TNF/NF-κB Signaling Pathway.
    Han X, Chen X, Han J, Zhong Y, Li Q, An Y.
    Int Heart J; 2020 Nov 28; 61(6):1258-1269. PubMed ID: 33191336
    [Abstract] [Full Text] [Related]

  • 22. MicroRNA-146a negatively regulates inflammation via the IRAK1/TRAF6/NF-κB signaling pathway in dry eye.
    Han R, Gao J, Wang L, Hao P, Chen X, Wang Y, Jiang Z, Jiang L, Wang T, Zhu L, Li X.
    Sci Rep; 2023 Jul 11; 13(1):11192. PubMed ID: 37433841
    [Abstract] [Full Text] [Related]

  • 23. Targeting MIAT reduces apoptosis of cardiomyocytes after ischemia/reperfusion injury.
    Chen L, Zhang D, Yu L, Dong H.
    Bioengineered; 2019 Dec 11; 10(1):121-132. PubMed ID: 30971184
    [Abstract] [Full Text] [Related]

  • 24. MiR-345-3p attenuates apoptosis and inflammation caused by oxidized low-density lipoprotein by targeting TRAF6 via TAK1/p38/NF-kB signaling in endothelial cells.
    Wei Q, Tu Y, Zuo L, Zhao J, Chang Z, Zou Y, Qiu J.
    Life Sci; 2020 Jan 15; 241():117142. PubMed ID: 31825793
    [Abstract] [Full Text] [Related]

  • 25. Chronic constriction injury-induced microRNA-146a-5p alleviates neuropathic pain through suppression of IRAK1/TRAF6 signaling pathway.
    Wang Z, Liu F, Wei M, Qiu Y, Ma C, Shen L, Huang Y.
    J Neuroinflammation; 2018 Jun 09; 15(1):179. PubMed ID: 29885668
    [Abstract] [Full Text] [Related]

  • 26. Effects of microRNA-146a on the proliferation and apoptosis of human osteoarthritis chondrocytes by targeting TRAF6 through the NF-κB signalling pathway.
    Zhong JH, Li J, Liu CF, Liu N, Bian RX, Zhao SM, Yan SY, Zhang YB.
    Biosci Rep; 2017 Apr 30; 37(2):. PubMed ID: 28314786
    [Abstract] [Full Text] [Related]

  • 27. Human urine-derived stem cells protect against renal ischemia/reperfusion injury in a rat model via exosomal miR-146a-5p which targets IRAK1.
    Li X, Liao J, Su X, Li W, Bi Z, Wang J, Su Q, Huang H, Wei Y, Gao Y, Li J, Liu L, Wang C.
    Theranostics; 2020 Apr 30; 10(21):9561-9578. PubMed ID: 32863945
    [Abstract] [Full Text] [Related]

  • 28. Pharmacological effects of β-d-mannuronic acid (M2000) on miR-146a, IRAK1, TRAF6 and NF-κB gene expression, as target molecules in inflammatory reactions.
    Mortazavi-Jahromi SS, Jamshidi MM, Farazmand A, Aghazadeh Z, Yousefi M, Mirshafiey A.
    Pharmacol Rep; 2017 Jun 30; 69(3):479-484. PubMed ID: 28324845
    [Abstract] [Full Text] [Related]

  • 29. MicroRNA-146a-5p Downregulates the Expression of P-Glycoprotein in Rats with Lithium-Pilocarpine-Induced Status Epilepticus.
    Deng X, Shao Y, Xie Y, Feng Y, Wu M, Wang M, Chen Y.
    Biol Pharm Bull; 2019 Jun 30; 42(5):744-750. PubMed ID: 31061316
    [Abstract] [Full Text] [Related]

  • 30. miR-205/IRAK2 signaling pathway is associated with urban airborne PM2.5-induced myocardial toxicity.
    Feng L, Wei J, Liang S, Sun Z, Duan J.
    Nanotoxicology; 2020 Nov 30; 14(9):1198-1212. PubMed ID: 32880505
    [Abstract] [Full Text] [Related]

  • 31. miR-146a promotes cervical cancer cell viability via targeting IRAK1 and TRAF6.
    Hu Q, Song J, Ding B, Cui Y, Liang J, Han S.
    Oncol Rep; 2018 Jun 30; 39(6):3015-3024. PubMed ID: 29693168
    [Abstract] [Full Text] [Related]

  • 32. Resveratrol protects BV2 mouse microglial cells against LPS-induced inflammatory injury by altering the miR-146a-5p/TRAF6/NF-κB axis.
    Ge YT, Zhong AQ, Xu GF, Lu Y.
    Immunopharmacol Immunotoxicol; 2019 Oct 30; 41(5):549-557. PubMed ID: 31530042
    [Abstract] [Full Text] [Related]

  • 33. miR-146a regulates inflammatory cytokine production in Porphyromonas gingivalis lipopolysaccharide-stimulated B cells by targeting IRAK1 but not TRAF6.
    Jiang S, Hu Y, Deng S, Deng J, Yu X, Huang G, Kawai T, Han X.
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar 30; 1864(3):925-933. PubMed ID: 29288795
    [Abstract] [Full Text] [Related]

  • 34. MicroRNA-146a-5p Negatively Regulates Pro-Inflammatory Cytokine Secretion and Cell Activation in Lipopolysaccharide Stimulated Human Hepatic Stellate Cells through Inhibition of Toll-Like Receptor 4 Signaling Pathways.
    Chen Y, Zeng Z, Shen X, Wu Z, Dong Y, Cheng JC.
    Int J Mol Sci; 2016 Jul 07; 17(7):. PubMed ID: 27399683
    [Abstract] [Full Text] [Related]

  • 35. Regulatory effects of miR-146a/b on the function of endothelial progenitor cells in acute ischemic stroke in mice.
    Su ZF, Sun ZW, Zhang Y, Wang S, Yu QG, Wu ZB.
    Kaohsiung J Med Sci; 2017 Aug 07; 33(8):369-378. PubMed ID: 28811005
    [Abstract] [Full Text] [Related]

  • 36. Troxerutin attenuates myocardial cell apoptosis following myocardial ischemia-reperfusion injury through inhibition of miR-146a-5p expression.
    Shu L, Zhang W, Huang G, Huang C, Zhu X, Su G, Xu J.
    J Cell Physiol; 2019 Jun 07; 234(6):9274-9282. PubMed ID: 30417352
    [Abstract] [Full Text] [Related]

  • 37. The role of β-d-mannuronic acid, as a new non-steroidal anti-inflammatory drug on expression of miR-146a, IRAK1, TRAF6, NF-κB and pro-inflammatory cytokines following a clinical trial in rheumatoid arthritis patients.
    Mortazavi-Jahromi SS, Ahmadzadeh A, Rezaieyazdi Z, Aslani M, Omidian S, Mirshafiey A.
    Immunopharmacol Immunotoxicol; 2020 Jun 07; 42(3):228-236. PubMed ID: 32223462
    [Abstract] [Full Text] [Related]

  • 38. MicroRNA-146a-5p attenuates liver fibrosis by suppressing profibrogenic effects of TGFβ1 and lipopolysaccharide.
    Zou Y, Cai Y, Lu D, Zhou Y, Yao Q, Zhang S.
    Cell Signal; 2017 Nov 07; 39():1-8. PubMed ID: 28739486
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome.
    Zilahi E, Tarr T, Papp G, Griger Z, Sipka S, Zeher M.
    Immunol Lett; 2012 Jan 30; 141(2):165-8. PubMed ID: 22033216
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 56.